09. 12(Fri)
09. 12(Fri) 08:30~10:00 Room 4
Shaping the Future of Lipid Management: Insights from the New Consensus and Current Dyslipidemia Trends
-
2024 KSoLA consensus on secondary dyslipidemia
Jae Hyun Bae Seoul National University, Republic of Korea 08:30~08:50 -
Understanding the progression of obesity-induced organ damage: Insights from the EAS staging system
Dae Young Cheon Hallym University, Republic of Korea 08:50~09:10 -
Sex-specific gaps in lipid management and ASCVD
Hyun-Jin Kim Hanyang University, Republic of Korea 09:10~09:30 - Panel Discussion 09:30~10:00
09. 12(Fri) 13:00~14:30 Room 4
Defining the Optimal LDL-C Target for Prevention of Atherosclerotic Cardiovascular and Cerebrovascular Disease
-
Optimal LDL-C goals for secondary prevention in high-risk patients - a cardiologist’s perspective
Hyun Sung Joh Seoul National University, Republic of Korea 13:00~13:20 -
Optimal LDL-C level for stroke prevention - insights from a neurologist’s perspective
Wookjin Yang University of Ulsan, Republic of Korea 13:20~13:40 -
Different LDL-C targets by duration of diabetes: what is the evidence? - an endocrinologist’s perspective
Young-Sang Lyu Chosun University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
09. 12(Fri) 16:45~18:15 Room 4
Immunometabolic Programming of Macrophages in Cardiovascular Injury and Repair
-
Glutamine homeostasis: an overlooked axis in cardiometabolic inflammation
Laurent Yvan-Charvet INSERM, France 16:45~17:05 -
Myeloid metabolism in the amplification and resolution of cardiac inflammation
Edward Thorp Northwestern University, USA 17:05~17:25 -
Therapeutic promise of ANGPTL4 in cardiovascular inflammation
Yong Sook Kim Chonnam National University, Republic of Korea 17:25~17:45 - Panel Discussion 17:45~18:15
